Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin-论文-万方医学网

首页> > Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin

Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin

导出原文传递

翻译打印收藏纠错

第一作者： Zalesak,M.

作者： Zalesak,M. ^[1] ; Siu,K. ^[2] ; Francis,K. ^[3] ; Yu,C. ; Alvrtsyan,H. ; Rao,Y. ; Walker,D. ; Sander,S. ; Miyasato,G. ; Matchar,D. ; Sanchez,H.

作者单位： Trinity Partners, 230 Third Ave, Waltham, MA 02451, United States ^[1] Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United States ^[2] Program in Health Services and Systems Research, Duke-NUS Graduate Medical School, Singapore ^[3]

关键词 Anticoagulants Atrial fibrillation Dabigatran Persistence Warfarin

发布时间 2022-09-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin

相似文献

同项目论文

相关期刊

检索历史 清除

Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin

相似文献

同项目论文

相关期刊

检索历史清除